
Amphastar Pharmaceuticals (NASDAQ: AMPH)
Amphastar Pharmaceuticals Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Amphastar Pharmaceuticals Company Info
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
News & Analysis
Why Shares of Amphastar Pharmaceuticals Rose Today
The company reported a record revenue year and increased EPS.
Why Amphastar Pharmaceuticals, Inc. is Soaring Today
Traders bid up shares on the news that the company's stock will be added to an index.
Valuation
Earnings Transcripts
Amphastar Pharmaceuticals (AMPH) Q2 2022 Earnings Call Transcript
AMPH earnings call for the period ending June 30, 2022.
Amphastar Pharmaceuticals (AMPH) Q1 2022 Earnings Call Transcript
AMPH earnings call for the period ending March 31, 2022.
Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript
AMPH earnings call for the period ending December 31, 2021.
Amphastar Pharmaceuticals, inc (AMPH) Q3 2021 Earnings Call Transcript
AMPH earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.